Dan Malarek, current CEO of Foundation Medicine Inc., appointed President and CEO of Roche Diagnostics North America, effective August 1, 2026 Malarek succeeds Brad Moore, who will retire at the end of July following nearly a decade of distinguished service at Roche Antonio Vergara appointed Chief Commercial Officer to lead U.S. commercial business units INDIANAPOLIS [...]

Enterprise-grade Signals software with guided onboarding positioned specifically for early-stage biotechs Science-first setup with ready-to-use Signals environments and modality-specific workflows Scalable informatics foundation that supports growth, collaboration and investor readiness WALTHAM, Mass. — Revvity, Inc. announced that its Revvity Signals Software business is launching Signals for Startups, a new program designed to help emerging biotechnology companies adopt [...]

Validation of HALO's Advanced Security Screening Technology Agilent Technologies, Inc. has led a multimillion dollar investment round in which other existing Blue Chip investors UK Innovation Science Seed Fund (UKI2S) and the Midland Engine Investment Fund (MEIF) also participated. The investment enables HALO to complete regulatory approval of its advanced security screening technology ahead of [...]

Adam Brown has been appointed Managing Director, assuming responsibility for the day-to-day leadership of the business As part of the transition, Richard Brown will become Chairman after 26 years as Managing Director, while John Clapham will continue supporting the company in his role as Founder. The changes reflect a planned succession process that combines continuity, [...]

TriLink's Complete Portfolio of CleanCap® Analogs are Patented in Major Jurisdictions Globally; TriLink is the Sole Authorized Manufacturer of CleanCap® Capping Analogs SAN DIEGO -- TriLink BioTechnologies, LLC (TriLink®), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has been granted a new patent from the China National Intellectual [...]

Luba Greenwood joins Cytosurge’s Board of Directors to support the company’s next phase of commercial growth and scientific progress as Cytosurge builds the causal data foundation for AI-driven drug discovery. ZURICH, Switzerland – Cytosurge, the pioneer of Same-Cell Biology, announces the election of Luba Greenwood, J.D., to its Board of Directors, effective July 9, 2026. Greenwood is a [...]

Applied AI and life sciences leader joins L7's executive team to advance the L7|SYNAPSE™ Agentic AI strategy across the customer base AUSTIN, Texas -- L7 Informatics, Inc., the company behind L7|ESP®, the Enterprise Science Platform that serves as an operating system for precision science, today named Ray Veeraraghavan, Ph.D., Vice President of Science and AI. [...]

Applied AI and life sciences leader joins L7’s executive team to advance the L7|SYNAPSE™ Agentic AI strategy across the customer base AUSTIN, Texas — L7 Informatics, Inc., the company behind L7|ESP®, the Enterprise Science Platform that serves as an operating system for precision science, today named Ray Veeraraghavan, Ph.D., Vice President of Science and AI. Reporting to CEO [...]

SHENZHEN, China — Bettersize Instruments announces the issuance of United States Patent No. 12,680,936 B2. The patent protects a method utilizing optical path difference for the analytical calculation of particle size gradation and solid content in two-phase flows. This patented Differential Path Measurement technology is the core operational framework of the DeepSizer 300, a specialized [...]

Brings decentralized, in-house DNA synthesis capabilities to researchers in a rapidly growing biotechnology market Paris, France DNA Script, the programmable biology company developing next-generation enzymatic DNA synthesis (EDS) technologies, today announced a new distribution agreement with Imperial Life Sciences (ILS), expanding access to the Company's SYNTAX® platform across India. Under the agreement, ILS will distribute [...]